2006•Clinical Lymphoma & MyelomaRequires access

Activity of Rituximab Monotherapy in Refractory Splenic Marginal Zone Lymphoma Complicated with Autoimmune Hemolytic Anemia

Alberto Fabbri, Alessandro Gozzetti, Stefano Lazzi, Mariapia Lenoci, Alessandro D’Amuri, Lorenzo Leoncini, Francesco Lauria

Open publisher page 23 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 23 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Autoimmune hemolytic anemia, Rituximab, Medicine, Splenic marginal zone lymphoma, Lymphoma, Refractory (planetary science), Anemia, Hemolytic anemia

Back to paper search Browse research topics Original source

Activity of Rituximab Monotherapy in Refractory Splenic Marginal Zone Lymphoma Complicated with Autoimmune Hemolytic Anemia — Research Paper | ScholarLens